US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 2.4210
  • -0.0190-0.78%
Trading Aug 26 12:25 ET
14.46MMarket Cap-992P/E (TTM)

Aytu BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aytu BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 18.301M--
May 15, 20242024/Q317.993M / 17.346M--
Feb 14, 20242024/Q222.934M / 21.745M--
Nov 14, 20232024/Q122.099M / 27.726M--
Sep 27, 20232023/Q430.732M / 27.694M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 18.301M--
May 15, 20242024/Q317.993M / 17.346M--
Feb 14, 20242024/Q222.934M / 21.745M--
Nov 14, 20232024/Q122.099M / 27.726M--
Sep 27, 20232023/Q430.732M / 27.694M--

Unlock Free Earnings Estimates

Aytu BioPharma Earnings Reports

  • Aytu BioPharma | 10-Q: Q3 2024 Earnings Report

    May 15 22:28 ET

  • Aytu BioPharma | 10-Q: Q2 2024 Earnings Report

    Feb 14 16:17 ET

  • Aytu BioPharma | 10-Q: Q1 2024 Earnings Report

    Nov 14, 2023 16:05 ET

  • Aytu BioPharma | 10-K: FY2023 Annual Report

    Oct 12, 2023 14:50 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg